203 related articles for article (PubMed ID: 27486977)
1. Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983-2012.
Wang S; Sun H; Xie Z; Li J; Hong G; Li D; Mallampati S; Zhou X; Zhou C; Zhang H; Cheng Z; Shan H; Ma H
Oncotarget; 2016 Sep; 7(37):59820-59833. PubMed ID: 27486977
[TBL] [Abstract][Full Text] [Related]
2. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
3. Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.
Flores YN; Datta GD; Yang L; Corona E; Devineni D; Glenn BA; Bastani R; May FP
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1193-1199. PubMed ID: 33737301
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.
Altekruse SF; McGlynn KA; Reichman ME
J Clin Oncol; 2009 Mar; 27(9):1485-91. PubMed ID: 19224838
[TBL] [Abstract][Full Text] [Related]
5. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
6. Racial Disparities and Sociodemographic Differences in Incidence and Survival Among Pediatric Patients in the United States With Primary Liver Cancer: A Surveillance, Epidemiology, and End Results (SEER) Population Study.
Nautsch F; Ludwig JM; Xing M; Johnson KM; Kim HS
J Clin Gastroenterol; 2018 Mar; 52(3):262-267. PubMed ID: 28617762
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma - United States, 2001-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(17):517-20. PubMed ID: 20448528
[TBL] [Abstract][Full Text] [Related]
8. Survival improvement in patients with non-small cell lung cancer between 1983 and 2012: Analysis of the Surveillance, Epidemiology, and End Results database.
Wang S; Sun T; Sun H; Li X; Li J; Zheng X; Mallampati S; Sun H; Zhou X; Zhou C; Zhang H; Cheng Z; Ma H
Tumour Biol; 2017 May; 39(5):1010428317691677. PubMed ID: 28459218
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Survival Rates of Patients with Stage III-IV Hodgkin Lymphoma According to Age, Sex, Race, and Socioeconomic Status, 1984-2013.
Li Y; Sun H; Yan Y; Sun T; Wang S; Ma H
Oncologist; 2018 Nov; 23(11):1328-1336. PubMed ID: 29739895
[TBL] [Abstract][Full Text] [Related]
10. Socioeconomic status and hepatocellular carcinoma in the United States.
Shebl FM; Capo-Ramos DE; Graubard BI; McGlynn KA; Altekruse SF
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1330-5. PubMed ID: 22669949
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of primary hepatic malignancies in U.S. children.
Darbari A; Sabin KM; Shapiro CN; Schwarz KB
Hepatology; 2003 Sep; 38(3):560-6. PubMed ID: 12939582
[TBL] [Abstract][Full Text] [Related]
12. Time-trends in incidence and prognosis of hepatocellular carcinoma in Denmark: A nationwide register-based cohort study.
Jepsen P; Andersen MW; Villadsen GE; Ott P; Vilstrup H
Liver Int; 2017 Jun; 37(6):871-878. PubMed ID: 27943604
[TBL] [Abstract][Full Text] [Related]
13. Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age-Period-Cohort Analysis.
Zhang X; El-Serag HB; Thrift AP
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):88-94. PubMed ID: 31712271
[TBL] [Abstract][Full Text] [Related]
14. Remoteness, race and social disadvantage: disparities in hepatocellular carcinoma incidence and survival in Queensland, Australia.
Clark PJ; Stuart KA; Leggett BA; Crawford DH; Boyd P; Fawcett J; Whiteman DC; Baade PD
Liver Int; 2015 Dec; 35(12):2584-94. PubMed ID: 25900432
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma: recent trends in the United States.
El-Serag HB
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S27-34. PubMed ID: 15508094
[TBL] [Abstract][Full Text] [Related]
16. A review of 218 pediatric cases of hepatocellular carcinoma.
Allan BJ; Wang B; Davis JS; Parikh PP; Perez EA; Neville HL; Sola JE
J Pediatr Surg; 2014 Jan; 49(1):166-71; discussion 171. PubMed ID: 24439603
[TBL] [Abstract][Full Text] [Related]
17. Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages.
Wang S; Tang J; Sun T; Zheng X; Li J; Sun H; Zhou X; Zhou C; Zhang H; Cheng Z; Ma H; Sun H
Sci Rep; 2017 May; 7(1):1339. PubMed ID: 28465554
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma in children: epidemiology and the impact of regional lymphadenectomy on surgical outcomes.
McAteer JP; Goldin AB; Healey PJ; Gow KW
J Pediatr Surg; 2013 Nov; 48(11):2194-201. PubMed ID: 24210185
[TBL] [Abstract][Full Text] [Related]
19. Geographic variation within the United States in the incidence of hepatocellular carcinoma.
Davila JA; Petersena NJ; Nelson HA; El-Serag HB
J Clin Epidemiol; 2003 May; 56(5):487-93. PubMed ID: 12812824
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.
Jones PD; Diaz C; Wang D; Gonzalez-Diaz J; Martin P; Kobetz E
Dig Dis Sci; 2018 Feb; 63(2):515-528. PubMed ID: 29275448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]